RNA-seq of engineered K562 cell line with t(7;12)(q36;p13) treated with SNX-2112 and OSI930
K562-t(7;12) cells (K562 background with CRISPR/Cas9 engineered t(7;12) translocation) were treated with SNX-2112 (210 nM), OSI930 (9.19 µM), or DMSO (control) (0.1%) for 24 hours.